510(k) Report

PMA · Approved

Recalled · 2003

Palacos R Bone Cement

P810020PMAApproved Feb 2, 1984995-day reviewClass II21 CFR 888.3027Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Smith & Nephew Richards, Inc. · LOD Bone Cement

Approved on Feb 2, 1984 through premarket approval, which rests on the device’s own clinical evidence after a 995-day review. 104 later devices descend from it. It has been recalled once.

Decided
Feb 2, 1984
Review
995 days
Class
Class II
Product code
LOD
Recalls
1

104 later devices descend from it, 9 citing it directly.

Descendants, by year cleared 2005: 6 descendants cleared2003: 5 descendants cleared2004: 5 descendants cleared2008: 3 descendants cleared2006: 3 descendants cleared2015: 3 descendants cleared2017: 2 descendants cleared2019: 8 descendants cleared2020: 6 descendants cleared2021: 5 descendants cleared2013: 2 descendants cleared2018: 2 descendants cleared2014: 1 descendant cleared2007: 2 descendants cleared2009: 3 descendants cleared2016: 1 descendant cleared2024: 14 descendants cleared2026: 10 descendants cleared2022: 5 descendants cleared2011: 1 descendant cleared2012: 2 descendants cleared2023: 9 descendants cleared2025: 6 descendants cleared19801990200020102020
  1. This deviceP810020 Palacos R Bone CementSmith & Nephew Richards, Inc. · 1984
  2. Descendant · cites it directly · 40 of its ownK030903 OsteopalHeraeus Kulzer GmbH & Co. KG · 2003
  3. Descendant · 2 generations on · 38 of its ownK050085 Osteopal VHeraeus Kulzer,GmbH · 2005
  4. Descendant · 3 generations on · 28 of its ownK150408 V-Steady, V-FastG21, S.R.L. · 2015
  5. Descendant · 4 generations on · 27 of its ownK200596 G21 Cement, VADER® Pedicle SystemIcotec AG · 2020 · Recalled
  6. Descendant · cites it directly · 25 of its ownK030086 Palacos R Bone Cement with GentamicinBiomet, Inc. · 2003

Showing 5 of 104 descendants. See all descendants

Descendants cleared per year

2003: 52004: 52005: 62006: 32007: 22008: 32009: 32011: 12012: 22013: 22014: 12015: 32016: 12017: 22018: 22019: 82020: 62021: 52022: 52023: 92024: 142025: 62026: 10
2003high 14 (2024) · low 0 (2010)2026

Most influential descendants

Showing 5 of 104 · See all
  • K030903OsteopalHeraeus Kulzer GmbH & Co. KG · 2003 · cites it directly40descendants
  • K050085Osteopal VHeraeus Kulzer,GmbH · 2005 · 2 generations on38descendants
  • K150408V-Steady, V-FastG21, S.R.L. · 2015 · 3 generations on28descendants
  • K200596G21 Cement, VADER® Pedicle SystemIcotec AG · 2020 · 4 generations on27descendants
  • K030086Palacos R Bone Cement with GentamicinBiomet, Inc. · 2003 · cites it directly25descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)P810020Palacos R Bone CementSmith & Nephew Richards, Inc.1984—
+1K030903OsteopalHeraeus Kulzer GmbH & Co. KG2003—
+2K050085Osteopal VHeraeus Kulzer,GmbH2005—
+3K150408V-Steady, V-FastG21, S.R.L.2015—
+4K200596G21 Cement, VADER® Pedicle SystemIcotec AG20201
+1K030086Palacos R Bone Cement with GentamicinBiomet, Inc.2003—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200350
200450
200560
200630
200720
200830
200930
201110
201220
201320
201410
201530
201610
201720
201820
201980
202060
202150
202250
202390
2024140
202560
2026100
FIG. 1 — Lineage of P810020, 1984–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LOD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LOD device

  1. #1 K254107 Refobacin Bone Cement R (110034355)score 11.8 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it? (104)

See all 104

9 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K030903OsteopalHeraeus Kulzer GmbH & Co. KG200340
K030086Palacos R Bone Cement with GentamicinBiomet, Inc.200325
K031673Refobacin -Palacos GHeraeus Kulzer GmbH & Co. KG200415
K030902Palacos RHeraeus Kulzer GmbH & Co. KG200313
K023012Smartset HV Bone CementDePuy Orthopaedics, Inc.200312
K050855Palamed GHeraeus Kulzer,GmbH20054
K051496Cobalt Bone CementBiomet, Inc.20053
K022688Versabond AB Bone CementSmith & Nephew, Inc.20040
K022251PalabondHeraeus Kulzer GmbH & Co. KG20030

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jan 17, 2003Not classifiedZ-0546-03OtherThere may be cracks in the blister pack overwrap for the glass ampoule containing the liquid monomer.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K030903 (Heraeus Kulzer GmbH & Co. KG, 2003) has gone furthest, with 40 descendants of its own.

How does its category compare?

All LOD devices

LOD Bone Cement: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LOD

1in 2025

2007: 22008: 12009: 32013: 22014: 12015: 42016: 12017: 32018: 22019: 42020: 32021: 42022: 32023: 22024: 12025: 12026 (partial year): 1
2007high 4 (2015) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LOD

277in 2022

2009: 103 days median2015: 138 days median2017: 96 days median2019: 90 days median2020: 139 days median2021: 95 days median2022: 277 days median
2007high 277 (2022) · low 90 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LOD

2in 2022

2014: 12017: 42020: 12022: 22026 (partial year): 2
2007high 4 (2017) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LOD

355in 2025

2007: 782008: 1342009: 1702010: 2912011: 4282012: 4122013: 5012014: 4652015: 5292016: 6152017: 8172018: 1,2952019: 2,3072020: 1,2942021: 7822022: 4722023: 4752024: 4922025: 355
2007high 2,307 (2019) · low 78 (2007)2025

MAUDE reports naming product code LOD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—078
20081—0134
200931030170
20100—0291
20110—0428
20120—0412
20132—0501
20141—1465
201541380529
20161—0615
20173964817
20182—01,295
201949002,307
2020313911,294
20214950782
202232772472
20232—0475
20241—0492
20251—0355
20261—2—
Cite this page

510(k) Report. “P810020: Palacos R Bone Cement.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P810020

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026